uniQure (QURE) EBITDA Margin (2016 - 2026)
uniQure (QURE) recorded quarterly EBITDA Margin of 1549.64% in Q1 2026, down 135.99% quarter-over-quarter from 656.66% in Q4 2025, and up 129925.0% on a YoY basis from N/an in Q1 2025.
uniQure (QURE) EBITDA Margin (2016 - 2026) Analysis & Trends
uniQure's EBITDA Margin history runs 11 years deep, the most recent figure standing at 1549.64% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 129925.0% year-over-year to 1549.64%; the TTM figure through Mar 2026 stood at 1188.02% (down 12205.0% YoY), while the FY2025 annual figure was 1269.68%, down 38910.0% from the prior year.
- EBITDA Margin was 1549.64% for Q1 2026 at uniQure, down from 656.66% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 40.41% in Q4 2022 to a low of 13558.35% in Q2 2022.
- Historically, EBITDA Margin has averaged 2728.45% across 5 years, with a median of 1549.64% in 2026.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 1364297 bps in 2022, then soared 1073341 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 40.41% in 2022, then plunged by 2623 bps to 1019.6% in 2023, then slumped by 30 bps to 1328.54% in 2024, then jumped by 51 bps to 656.66% in 2025, then sank by 136 bps to 1549.64% in 2026.
- The last three EBITDA Margin figures came in at 1549.64% (Q1 2026), 656.66% (Q4 2025), and 2171.6% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -1,549.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,549.64% |
| Dec 31, 2025 | -656.66% |
| Sep 30, 2025 | -2,171.60% |
| Jun 30, 2025 | -813.70% |
| Mar 31, 2025 | -2,848.88% |
| Dec 31, 2024 | -1,328.54% |
| Sep 30, 2024 | -1,956.97% |
| Jun 30, 2024 | -508.51% |
| Mar 31, 2024 | -802.68% |
| Dec 31, 2023 | -1,019.60% |
| Sep 30, 2023 | -6,800.92% |
| Jun 30, 2023 | -2,824.94% |
| Mar 31, 2023 | -1,341.41% |
| Dec 31, 2022 | 40.41% |
| Sep 30, 2022 | -5,053.62% |
| Jun 30, 2022 | -13,558.35% |
| Mar 31, 2022 | -3,187.95% |
| Dec 31, 2021 | -4.79% |
| Sep 30, 2021 | -2,504.73% |
| Jun 30, 2021 | 84.62% |